Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.
Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.
Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.
Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.
Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.
Relating to hospital patients' rights and hospital policies and procedures; providing an administrative penalty.
Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.
Relating to the Rita Littlefield Chronic Kidney Disease Centralized Resource Center established within the Health and Human Services Commission.
Relating to the Rita Littlefield Chronic Kidney Disease Centralized Resource Center established within the Health and Human Services Commission.
Relating to authorizing the possession, use, cultivation, distribution, delivery, sale, and research of medical cannabis for medical use by patients with certain medical conditions and the licensing of medical cannabis organizations; authorizing fees.